文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

中等量静脉液体复苏与脓毒症死亡率降低相关

Moderate IV Fluid Resuscitation Is Associated With Decreased Sepsis Mortality.
PubMed 文献 · Crit Care Med · 2024-08-23
一句话结论在190,682例脓毒症及脓毒性休克患者中,中等量静脉液体复苏(4.0 L)与风险校正死亡率较极低量(1.6 L)或极高量(6.1 L)组降低2.5%相关,p<0.01。

该研究为Premier医疗数据库的回顾性分析,纳入2016年1月1日至2019年12月31日美国612家医院中从急诊科收入ICU的脓毒症及脓毒性休克患者190,682例。基于患者特征和病情严重程度预测的静脉液体量窄幅均值为3.6-4.5 L(95%范围),但实际给予量变异很大(95%范围1.7-7.4 L)。按主治医师实践分为五组后,中等量组(4.0 L;IQR 2.4-5.1 L)的风险校正死亡率较极低量组(1.6 L;IQR 1.0-2.5 L)或极高量组(6.1 L;IQR 4.0-9.0 L)降低2.5%,p<0.01;医院内医师间差异而非医院间实践差异解释了观察到的变异。作者认为中等量液体复苏与脓毒症死亡率降低相关,应在未来随机对照试验中检验。

要点

  • 在190,682例脓毒症及脓毒性休克患者中,中等量静脉液体组(4.0 L;IQR 2.4-5.1 L)风险校正死亡率较极低量组(1.6 L;IQR 1.0-2.5 L)或极高量组(6.1 L;IQR 4.0-9.0 L)降低2.5%,p<0.01。
  • 基于患者特征和病情严重程度预测的静脉液体量窄幅均值为3.6-4.5 L(95%范围),但实际给予量变异很大(95%范围1.7-7.4 L)。
  • 按主治医师实践分为五组后,医院内医师间差异而非医院间实践差异解释了静脉液体量的变异。
  • 作者认为中等量静脉液体复苏与脓毒症死亡率降低相关,应在未来随机对照试验中检验。

适用人群与场景

  • 2016年1月1日至2019年12月31日从急诊科收入ICU的脓毒症及脓毒性休克患者,共190,682例,来自美国612家医院。

研究设计与关键结果

  • 研究设计为Premier医疗数据库的回顾性分析,纳入美国612家医院190,682例从急诊科收入ICU的脓毒症及脓毒性休克患者。
  • 基于患者特征和病情严重程度预测的静脉液体量窄幅均值为3.6-4.5 L(95%范围),实际给予量95%范围为1.7-7.4 L。
  • 按主治医师实践分为五组:中等量组液体量4.0 L(IQR 2.4-5.1 L),极低量组1.6 L(IQR 1.0-2.5 L),极高量组6.1 L(IQR 4.0-9.0 L)。
  • 中等量组风险校正死亡率较极低量组或极高量组降低2.5%,p<0.01。
  • 医院内和医院间静脉液体复苏实践分析显示,医院内医师间变异而非医院间实践差异解释了观察到的变异。

证据类型、等级与局限

  • 证据类型:回顾性分析(Premier医疗数据库)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为中等量静脉液体复苏与脓毒症死亡率降低相关,应在未来随机对照试验中检验。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Significant practice variation exists in the amount of resuscitative IV fluid given to patients with sepsis. Current research suggests equipoise between a tightly restrictive or more liberal strategy but data is lacking on a wider range of resuscitation practices. We sought to examine the relationship between a wide range of fluid resuscitation practices and sepsis mortality and then identify the primary driver of this practice variation.

DESIGN: Retrospective analysis of the Premier Healthcare Database.

SETTING: Six hundred twelve U.S. hospitals.

PATIENTS: Patients with sepsis and septic shock admitted from the emergency department to the ICU from January 1, 2016, to December 31, 2019.

INTERVENTIONS: The volume of resuscitative IV fluid administered before the end of hospital day- 1 and mortality.

MEASUREMENTS AND MAIN RESULTS: In total, 190,682 patients with sepsis and septic shock were included in the analysis. Based upon patient characteristics and illness severity, we predicted that physicians should prescribe patients with sepsis a narrow mean range of IV fluid (95% range, 3.6-4.5 L). Instead, we observed wide variation in the mean IV fluids administered (95% range, 1.7-7.4 L). After splitting the patients into five groups based upon attending physician practice, we observed patients in the moderate group (4.0 L; interquartile range [IQR], 2.4-5.1 L) experienced a 2.5% reduction in risk-adjusted mortality compared with either the very low (1.6 L; IQR, 1.0-2.5 L) or very high (6.1 L; IQR, 4.0-9.0 L) fluid groups p < 0.01). An analysis of within- and between-hospital IV fluid resuscitation practices showed that physician variation within hospitals instead of practice differences between hospitals accounts for the observed variation.

CONCLUSIONS: Individual physician practice drives excess variation in the amount of IV fluid given to patients with sepsis. A moderate approach to IV fluid resuscitation is associated with decreased sepsis mortality and should be tested in future randomized controlled trials.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Corl KA, Levy MM, Holder AL, et al. Moderate IV Fluid Resuscitation Is Associated With Decreased Sepsis Mortality. Crit Care Med. 2024. PMID: 39177437. doi:10.1097/CCM.0000000000006394

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。